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Tuberculosis (TB) is a contagious disease spread by people who have 
the bacteria Mycobacterium tuberculosis within their lungs. These bacteria 
are expelled during coughing and can then infect others. TB is mainly 
present in developing countries, but because travel is so easy these 
days, a single infected person could potentially spread TB to people in 
several different places. TB can become a fatal disease, especially in 
children, so vaccination is recommended shortly after birth in countries 
that have a lot of infected people. Today, the only available vaccine 
does not work against the latent form of infection. During latent TB, 
M. tuberculosis remains “dormant” or hiding, within an infected person 
without causing trouble, but upon weakening of the immune (defense) 
system, it “wakes up” and causes disease, including coughing and 
the potential to spread to other people. In this article, I present ideas 
to improve vaccines to prevent latent TB, as a way to decrease the 
chances of starting new infectious cycles upon “awakening” of the dormant 
bacteria.
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INTRODUCTION
What is a vaccine? In the simplest terms possible, a vaccine is a mixture made 
of one or more microbes (viruses or bacteria) or parts of these organisms that 
aims to stimulate our body’s defenses, in order to help the body to eliminate 
the microbe or reduce the damage caused by any illness the microbe causes 
[1], for example, uncontrolled coughing, weight loss, paralysis, and very high 
fever, among others.
The goal of a vaccine is to prevent disease, and one of the greatest challenges 
in creating a vaccine is to stimulate the body enough to allow our defenses 
against that organism to arise while not causing any unpleasant side effects 
such as swelling and pain. Usually, scientists perform experiments to deter-
mine how well a potential vaccine can protect against an infection, as well as 
to figure out how safe the vaccine is. Vaccines work differently in different 
people, due to factors in the environment (for example, other infectious 
microbes that the person may be exposed to, or the quality and amount of 
food that person eats) as well as basic differences in the way peoples’ defense 
systems work. These differences make it a good idea to test vaccines in differ-
ent groups of people in what are called clinical studies. It is also important 
to keep in mind that some vaccines might not work in different countries 
because the microbes there might be slightly different than the microbes 
used to develop the vaccine.
WHY IS IT NECESSARY TO FIND A BETTER VACCINE 
AGAINST TUBERCULOSIS?
Tuberculosis (TB) is a very important public health problem. It is esti-
mated that in 2014, 9.6 million people developed TB, and almost 2 million 
people died of this disease, where India, Indonesia, and China presented 
almost half of the cases occurring in the world [2]. TB is caused by a 
bacteria called Mycobacterium tuberculosis that is spread from person to 
person through the air, when someone with the disease coughs, talks, 
or sneezes. It is estimated that one third of the people infected with this 
bacteria do not get sick but still have the bacteria hiding in their bodies, 
in what doctors call a “latent” (or dormant) state.
There is only one vaccine currently approved for TB in humans, and it is 
called Mycobacterium bovis Bacillus Calmette–Guérin (BCG). This vac-
cine has been given to more than 3 billion people since it was developed 
in 1921, with around 115 million doses per year given to newborns. 
The BCG vaccine is made from living bacteria that have been weak-
ened in the lab so that they are unable to cause disease. This type of 
vaccine, using weak but still living bacteria, is called a live attenuated 
vaccine.
Vaccine
A mixture made of one 
or more microbes 
(viruses or bacteria) or 
parts of these 
organisms that aims to 
stimulate our body’s 
defenses, in order to 
help the body to 
eliminate the microbe 
or reduce the damage 
caused by any illness 
the microbe causes [1], 
for example, 
uncontrolled coughing, 
weight loss, paralysis, 
and very high fever, 
among others.
Microbes
Tiny, microscopic 
organisms (in the range 
of one millionth of a 
meter, or even smaller 
than this) that can only 
be seen using tools 
called microscopes. 
Some microbes can 
cause disease to 
people, animals or 
plants, and others can 
be used to produce 
yogurt, cheese, bread, 
or wine, among other 
foods.
BCG
Bacille of Calmette–
Guérin, an attenuated 
from Mycobacterium 
bovis that does not 
cause disease to 
healthy people.
Attenuated
A microbe that is 
normally capable of 
causing disease, which 
has been weakened in 
the lab so that it is no 
longer harmful, yet can 
be used by the immune 
system to promote the 
rise of defenses.
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Live attenuated vaccines, such as BCG, usually work very well to prevent 
infections with the real, disease-causing organism. Unfortunately the BCG 
live vaccine is not good at protecting people against every one of the differ-
ent types of TB that exist in nature – it protects against some types but not 
others. Also, in people with latent TB, the BCG vaccine does not fully prevent 
the dormant bacteria from “waking up” and causing disease. So, if we really 
want to protect everyone against TB, we know that a stronger, better vaccine 
is necessary.
VACCINE CANDIDATES AGAINST LATENT 
TUBERCULOSIS
In the last 5 years or so, scientists have been trying to create a vaccine that 
will keep people with latent TB infection from getting sick. The strategies and 
reasons why scientists think these new vaccine candidates will be better than 
current BCG, are described in Table 1. One of these possible new vaccines is 
made from a mixture of two substances that are found in mice with TB: one 
substance is produced by the TB bacteria when the mice are actually sick with 
TB and the other is produced by the bacteria during chronic infection. So 
far, this vaccine has been tested in both mice and a kind of monkey called a 
macaque. In both mice and monkeys, the vaccine seems to help prevent ani-
mals with latent infections from getting sick [3]. Other types of vaccines are 
being tested in animals too, although so far none of them look very promising.
My research group has also been working hard to develop a better vaccine 
against TB. We took the same BCG bacteria that is used in the current 
vaccine and modified it in the lab by deleting one of its genes. Genes are 
the “instructions” inside a cell that help it to live and grow and perform 
its functions. We found that eliminating one specific gene made the bacte-
ria easier for the body to see and therefore easier for the immune system 
Latent 
infection
A condition where a 
microbe remain within a 
person or animal (or 
even plants) without 
causing any visible 
damage to them.
Gene
Part of the hereditary 
material present in 
every living cell and that 
helps the cell to work at 
its full capacity when 
used or needed.
Table 1 | Strategies for developing new vaccines against 
tuberculosis.
What is the strategy? Why is it expected to work?
Remove genes from harmful Mycobacterium 
tuberculosis
It decreases the ability of the harmful bacteria to 
cause disease
Add genes from disease-causing 
Mycobacterium tuberculosis, to the safe, 
attenuated BCG bacteria
It makes the “safe-to-use” bacteria look more 
like the bacteria that causes disease, which 
activates the immune system better
Mix bacterial substances known to be 
produced in the body during infection with 
tuberculosis
It stimulates the immune system and helps the 
body to defend itself against several forms of the 
harmful bacteria
Modify or change the BCG bacteria so that it 
looks more like the natural forms of TB that 
people actually get infected with
It increases the chance that the immune system 
will recognize the harmful bacteria when it sees it
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to fight off. We also discovered that, at least in mice, this modified BCG 
vaccine helps to prevent dormant bacteria from waking up and causing 
disease. That means that our new vaccine might be better than the vaccine 
available today!
We just got approval for our results being published in a scientific journal, 
and we are also planning further experiments to make sure this vaccine 
really does help to control latent TB. We hope that we have created a vac-
cine that will finally work to protect people against all the different types 
of TB. We also hope that this vaccine will be safe and useful in people 
with other diseases, such as HIV. HIV-infected people are more likely to 
get sick from TB because their immune systems are weak. Maybe a new 
vaccine will eventually be able to slow or stop the spread of TB in the 
world. Figure 1 shows basic aspects of latent TB infection and vaccine 
development.
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figure 1
Schematic representation 
of latent tuberculosis 
infection and vaccine 
development.
Figure 1
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